Loading clinical trials...
Showing 1-1 of 1 trials
NCT06202027
The objective of this post-marketing surveillance (PMS) study is to assess the safety and effectiveness of CRYSVITA injection 10, 20, and 30mg, equivalent to in routine clinical settings